These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 23991075

  • 1. Comparative analysis of TGF-β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines.
    Dzieran J, Fabian J, Feng T, Coulouarn C, Ilkavets I, Kyselova A, Breuhahn K, Dooley S, Meindl-Beinker NM.
    PLoS One; 2013; 8(8):e72252. PubMed ID: 23991075
    [Abstract] [Full Text] [Related]

  • 2. Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma.
    Feng T, Dzieran J, Gu X, Marhenke S, Vogel A, Machida K, Weiss TS, Ruemmele P, Kollmar O, Hoffmann P, Grässer F, Allgayer H, Fabian J, Weng HL, Teufel A, Maass T, Meyer C, Lehmann U, Zhu C, Mertens PR, Gao CF, Dooley S, Meindl-Beinker NM.
    Clin Sci (Lond); 2015 Jun; 128(11):761-74. PubMed ID: 25602745
    [Abstract] [Full Text] [Related]

  • 3. Systematic Analysis of Cytostatic TGF-Beta Response in Mesenchymal-Like Hepatocellular Carcinoma Cell Lines.
    Gungor MZ, Uysal M, Ozturk M, Senturk S.
    J Gastrointest Cancer; 2021 Dec; 52(4):1320-1335. PubMed ID: 34463913
    [Abstract] [Full Text] [Related]

  • 4. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
    Mu X, Lin S, Yang J, Chen C, Chen Y, Herzig MC, Washburn K, Halff GA, Walter CA, Sun B, Sun LZ.
    PLoS One; 2013 Dec; 8(5):e63436. PubMed ID: 23704908
    [Abstract] [Full Text] [Related]

  • 5. Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-β-susceptible hepatocellular carcinoma cells.
    Jiang L, Lai YK, Zhang JF, Chan CY, Lu G, Lin MC, He ML, Li JC, Kung HF.
    World J Gastroenterol; 2012 May 07; 18(17):2035-42. PubMed ID: 22563190
    [Abstract] [Full Text] [Related]

  • 6. CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.
    Yan X, Wu J, Jiang Q, Cheng H, Han JJ, Chen YG.
    J Mol Cell Biol; 2018 Feb 01; 10(1):48-59. PubMed ID: 29036306
    [Abstract] [Full Text] [Related]

  • 7. Heme oxygenase-1/carbon monoxide axis suppresses transforming growth factor-β1-induced growth inhibition by increasing ERK1/2-mediated phosphorylation of Smad3 at Thr-179 in human hepatocellular carcinoma cell lines.
    Park SJ, Lee SK, Lim CR, Park HW, Liu F, Kim SJ, Kim BC.
    Biochem Biophys Res Commun; 2018 Apr 06; 498(3):609-615. PubMed ID: 29524413
    [Abstract] [Full Text] [Related]

  • 8. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H, Ju HL, Chung SI, Cho KJ, Eun JW, Nam SW, Han KH, Calvisi DF, Ro SW.
    Gastroenterology; 2017 Nov 06; 153(5):1378-1391.e6. PubMed ID: 28734833
    [Abstract] [Full Text] [Related]

  • 9. Expression of Oct4 in HCC and modulation to wnt/β-catenin and TGF-β signal pathways.
    Yuan F, Zhou W, Zou C, Zhang Z, Hu H, Dai Z, Zhang Y.
    Mol Cell Biochem; 2010 Oct 06; 343(1-2):155-62. PubMed ID: 20549546
    [Abstract] [Full Text] [Related]

  • 10. Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma.
    Murata M, Yoshida K, Yamaguchi T, Matsuzaki K.
    World J Gastroenterol; 2014 Nov 07; 20(41):15018-27. PubMed ID: 25386050
    [Abstract] [Full Text] [Related]

  • 11. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.
    Chen CL, Tsukamoto H, Liu JC, Kashiwabara C, Feldman D, Sher L, Dooley S, French SW, Mishra L, Petrovic L, Jeong JH, Machida K.
    J Clin Invest; 2013 Jul 07; 123(7):2832-49. PubMed ID: 23921128
    [Abstract] [Full Text] [Related]

  • 12. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.
    Wang Y, Wu J, Lin B, Li X, Zhang H, Ding H, Chen X, Lan L, Luo H.
    Toxicology; 2014 Dec 04; 326():9-17. PubMed ID: 25268046
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma.
    Bi JG, Zheng JF, Li Q, Bao SY, Yu XF, Xu P, Liao CX.
    Int J Biochem Cell Biol; 2019 Jan 04; 106():107-116. PubMed ID: 30503931
    [Abstract] [Full Text] [Related]

  • 14. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
    Sun H, Peng Z, Tang H, Xie D, Jia Z, Zhong L, Zhao S, Ma Z, Gao Y, Zeng L, Luo R, Xie K.
    Oncogene; 2017 May 25; 36(21):2957-2968. PubMed ID: 28192402
    [Abstract] [Full Text] [Related]

  • 15. TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells.
    Damdinsuren B, Nagano H, Kondo M, Natsag J, Hanada H, Nakamura M, Wada H, Kato H, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono K, Monden M.
    Oncol Rep; 2006 Feb 25; 15(2):401-8. PubMed ID: 16391861
    [Abstract] [Full Text] [Related]

  • 16. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling.
    Hu X, Rui W, Wu C, He S, Jiang J, Zhang X, Yang Y.
    J Gastroenterol Hepatol; 2014 Jun 25; 29(6):1284-91. PubMed ID: 24329763
    [Abstract] [Full Text] [Related]

  • 17. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
    Zong G, Xu Z, Zhang S, Shen Y, Qiu H, Zhu G, He S, Tao T, Chen X.
    Dig Dis Sci; 2016 Aug 25; 61(8):2303-2314. PubMed ID: 27074923
    [Abstract] [Full Text] [Related]

  • 18. Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma.
    Ueno T, Hashimoto O, Kimura R, Torimura T, Kawaguchi T, Nakamura T, Sakata R, Koga H, Sata M.
    Int J Oncol; 2001 Jan 25; 18(1):49-55. PubMed ID: 11115538
    [Abstract] [Full Text] [Related]

  • 19. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway.
    Li X, Zeng X.
    Cell Biol Int; 2020 Feb 25; 44(2):467-476. PubMed ID: 31617643
    [Abstract] [Full Text] [Related]

  • 20. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell.
    Liu X, Yang Y, Zhang X, Xu S, He S, Huang W, Roberts MS.
    J Gastroenterol Hepatol; 2010 Feb 25; 25(2):420-6. PubMed ID: 19793165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.